Reason for request
Inclusion
Clinical Benefit
| Moderate |
Moderate AB pending re-assessment of oral antihistamines. |
Clinical Added Value
| no clinical added value |
No improvement in actual benefit (IAB V) compared with other oral H1 antihistamines available in oral form. |
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
MKdDuNBzC5mK6EeR
Listen
